Work

Abstract 4780: Engineered ICAM-1 refractory trastuzumab improves its therapeutic activity against HER2-positive cancers in native and antibody-drug conjugate (ADC) format

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-4780

Authors: J. Bradford Kline, Luigi Grasso, Nicholas C. Nicolaides

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409635480

Cites:

Cited by:

Related to: 10